Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose stools and diarrhoea are among the most commonly reported side effects of Mounjaro (tirzepatide), affecting a significant proportion of people at some point during treatment — most often in the first few weeks or after a dose increase. For most people the gut settles within days to a couple of weeks as the body adjusts; for a few, it persists or becomes severe enough to need medical input. Mounjaro is a prescription-only medicine: a GPhC-registered prescriber assesses suitability, including your medical history and any existing gut conditions, before treatment begins. The full Mounjaro side-effect picture covers more than the gut alone, but diarrhoea tends to be the question our clinical team hears most in those early weeks.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works by activating two gut-hormone receptors simultaneously (GIP and GLP-1) which slow the rate at which the stomach empties food into the small intestine. That slower transit is deliberate: it prolongs the feeling of fullness. The trade-off is that the bowel itself can respond unpredictably, especially while it is adjusting to a new hormonal signal. Loose stools or outright diarrhoea are the result of that adjustment, not a sign that something has gone wrong with the medicine itself.
The pattern is fairly predictable. Symptoms are most likely in the first four to eight weeks of treatment or in the days following a dose increase. The licensed starting strength of 2.5mg exists partly because a gentler introduction gives the digestive system time to adapt before the dose climbs. Our Mounjaro overview explains the full titration schedule in plain terms. Once your body has settled at a given dose, gut symptoms usually reduce noticeably, though they can briefly return each time the dose steps up.
Diet makes a real difference here. Foods that are high in fat or very rich tend to worsen GI symptoms on tirzepatide because the slower gastric emptying amplifies their effect. Smaller, more frequent meals and cutting back on greasy or heavily processed food helps many people get through the adjustment phase more comfortably. The NHS tirzepatide medicines page lists practical self-care steps alongside the clinical side-effect profile.
Hydration is the priority. Frequent loose stools deplete fluid and electrolytes faster than most people expect, and mild dehydration can make every other symptom (fatigue, headache, dizziness) noticeably worse. Sipping water steadily through the day matters more than drinking large amounts at once. If you keep a water bottle in your gym bag or by the kettle, that habit is worth leaning on.
Oral rehydration sachets (available over the counter at any pharmacy) can help replace electrolytes lost during a bad episode. Plain foods (rice, toast, cooked vegetables) tend to be better tolerated than rich or spiced meals while symptoms are active. Caffeine and alcohol both increase gut motility and are worth reducing temporarily.
On injection timing: some people find that symptoms are mildest when they inject in the evening, so the peak effect happens overnight. That said, injection timing is a decision for you and your prescriber, not something to change without checking first. More detail on managing diarrhoea specifically during Mounjaro treatment covers dietary and timing strategies in depth. If diarrhoea is disrupting daily life or showing no sign of improving after two to three weeks at a stable dose, that is worth raising at your next clinical review rather than waiting it out.
Most gut upset from Mounjaro is unpleasant but not dangerous. There are exceptions, and knowing them is genuinely important.
Get urgent medical help (call 111 or go to A&E) if you experience severe stomach pain that does not ease, particularly pain that spreads toward the back, with or without vomiting. This symptom combination can indicate acute pancreatitis, a serious condition. In January 2026 the MHRA issued a Drug Safety Update formally highlighting acute pancreatitis as a known but infrequent risk with GLP-1 medicines, including tirzepatide. The risk is low, but the symptom pattern is distinctive enough that it should never be dismissed as ordinary stomach upset.
Also seek same-day or urgent medical input if: diarrhoea is severe and has continued for more than 48 hours without any improvement; you are unable to keep fluids down; you notice signs of significant dehydration (very dark urine, dizziness when standing, confusion); or you have blood in your stool. If you have a history of gallbladder problems, be aware that gallbladder-related symptoms (upper right abdominal pain, nausea after eating) can also occur on tirzepatide and warrant prompt assessment. Our page on Mounjaro and pancreatitis history covers the relevant background for anyone with prior pancreatic concerns.
Report persistent or unexpected side effects through the MHRA's Yellow Card scheme. It is a straightforward online form and directly informs ongoing medicine safety monitoring in the UK. Our prescribers also welcome contact if something is worrying you between reviews, reach our team here.
Diarrhoea that does not settle, or that returns severely with every dose increase, is clinical information, not a reason to stop treatment quietly without advice. Your prescriber may recommend slowing the titration schedule, staying at a lower dose for longer, or, in rare cases, pausing treatment temporarily while your gut recovers.
This is one reason why clinical oversight across a course of treatment matters. At nume, every repeat order is reviewed by a GPhC-registered prescriber before it is dispensed, there is no automatic renewal. If something has changed, including new or worsening gut symptoms, it is factored into that review. Practical guidance on stopping or reducing diarrhoea from Mounjaro outlines the steps your prescriber is likely to walk through with you. If you have not yet started treatment and are weighing up the side-effect profile, speaking to our prescribers as part of a free consultation is the right place to start, side effects, including how the gut typically responds, are part of every assessment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.